ada.enesco, Author at European Medical Journal - Page 10 of 27

Study Finds Pregnant Women Rarely Included in Clinical Research

The researchers reviewed over 90,000 randomised clinical trials of which, only 0.8% included pregnant participants.

Patients with Vitiligo Show No Increased Risk of Cancer

Research shows patients with vitiligo have no increased cancer risk, with reduced risks for melanoma, lung, and bladder cancers.

Hyperuricaemia in Severe Malaria Linked to Higher Mortality

Elevated uric acid levels in children with severe malaria are associated with significantly increased risks of death and long-term cognitive impairment.

High-Dose Vitamin C Extends Survival in Metastatic Pancreatic Cancer

Adding high-dose intravenous vitamin C to standard chemotherapy significantly improves survival in patients with metastatic pancreatic cancer.

Stronger Topical Steroids Show Greater Benefit for Moderate Atopic Dermatitis in Children

Potent corticosteroids provide superior symptom relief for moderate atopic dermatitis flare-ups in children, enhancing primary care management.

Health Disparities in MASLD Among Hispanic Adults

Data from 22 studies, encompassing 756,088 subjects, including 62,072 Hispanic adults, revealed striking findings.

TRILUMINATE Imaging Substudy: Sustained Cardiac Remodelling with TriClip

New imaging data show TriClip reduces tricuspid regurgitation and reverses cardiac remodeling, sustaining benefits for one year.

Targeting MRI-Detected Inflammation Improves Axial Spondyloarthritis Management

A groundbreaking analysis of the ESTHER trial reveals that resolution of MRI-detected inflammation in the sacroiliac joints is strongly linked to improved clinical outcomes in patients with axial spondyloarthritis undergoing long-term anti-TNF therapy.

Non-Hormonal Therapies Reduce Menopause Symptoms

Elinzanetant and fezolinetant ease menopause symptoms, with elinzanetant improving sleep and reducing side effects.

Increased Short-Term Risk of Thyroid Cancer After Starting GLP-1RA Therapy

A recent study has revealed an increased risk of thyroid cancer diagnoses within the first year of starting GLP-1RA therapy.